{"id":"NCT00176904","sponsor":"Masonic Cancer Center, University of Minnesota","briefTitle":"Stem Cell Transplant for Inborn Errors of Metabolism","officialTitle":"Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation","status":"COMPLETED","phase":"PHASE2","dates":{"start":"1995-01","primaryCompletion":"2010-06","completion":"2010-06","firstPosted":"2005-09-15","resultsPosted":"2011-06-10","lastUpdate":"2017-12-28"},"enrollment":135,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Adrenoleukodystrophy","Metachromatic Leukodystrophy","Globoid Cell Leukodystrophy","Gaucher's Disease","Fucosidosis","Wolman Disease","Niemann-Pick Disease","Batten Disease","GM1 Gangliosidosis","Tay Sachs Disease","Sandhoff Disease"],"interventions":[{"type":"PROCEDURE","name":"Stem Cell Transplant","otherNames":["Bone marrow transplant"]},{"type":"DRUG","name":"Busulfan, Cyclophosphamide, Antithymocyte Globulin","otherNames":["Busulfex, Cytoxan, ATG"]}],"arms":[{"label":"Treated Patients","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the safety and engraftment of donor hematopoietic cells using this conditioning regimen in patients undergoing a hematopoietic (blood forming) cell transplant for an inherited metabolic storage disease.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"100 Days, 1 Year and 3 Years","effectByArm":[{"arm":"Patients Treated With Stem Cell Transplant","deltaMin":120,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":14,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21586746"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":62,"n":135},"commonTop":[]}}